|
Volumn 4, Issue 2, 2000, Pages 77-85
|
Humanized antibodies as potential drugs for therapeutic use.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
ANIMAL;
ANTIBODY SPECIFICITY;
CHEMISTRY;
CLINICAL TRIAL;
GENETIC ENGINEERING;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MOUSE;
PROTEIN ENGINEERING;
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
CLINICAL TRIALS;
GENETIC ENGINEERING;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOTHERAPY;
MICE;
PROTEIN ENGINEERING;
RECOMBINANT PROTEINS;
|
EID: 0034171075
PISSN: 11255552
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (18)
|
References (73)
|